AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75N93019C00035BLUEWILLOW BIOLOGICS INC
Overview
Award facts
- Net obligations
- $3.30M
- $3,295,688of $3.30M potential value
- Outlays (paid to date)
- $2.00M
- $2.00M paid of $3.30M obligated$2,001,300
- Period of performance
- Sep 1, 2019 to Aug 31, 2024
- Ended
- Modifications
- 12
- Latest action Nov 22, 2024
- Contract type
- Definitive contract
- PIID 75N93019C00035
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
Dates and value
- Award date
- Signed on Aug 23, 2019
- Potential end of performance
- Aug 30, 2024
- Current value
- $3,295,688Base and exercised options
- Potential value (if all options are exercised)
- $3,295,688
Obligations by fiscal year of action
- FY2023: $79,300
- FY2020: $2,916,500
- FY2019: $299,888
Total across 3 fiscal years: $3,295,688
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 22, 2024. View on USAspending · Recipient on SAM.gov
Recipient
LocationANN ARBOR, MI
UEIRL3UZ5ZDKFT8
CAGE code3HT71
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBLUEWILLOW BIOLOGICS INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Ann Arbor, Washtenaw County, Michigan 48105-2965
- Congressional district (place of performance)
- MI-06As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 10
Solicitation and notices
- Solicitation ID
- PHS20191(as reported)
- Solicitation date
- Jul 18, 2018
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Development of nanovax tm (oil in water nanoemulsion adjuvant) formulated allergens as intranasal im
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 23, 2019Base obligation at award: $299,888
- Latest action
- Nov 22, 2024 — CloseoutModification P00012; administrative: no change in scope or value
- Latest substantive action
- Aug 28, 2020 — Supplemental agreement (within scope)Modification P00002; obligation change +$2,916,500
- Latest funding action
- Jun 20, 2023 — Funding onlyModification P00011; obligation change +$79,300; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action8
- Supplemental agreement (within scope)1
- Funding only1
- Change order1
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Research program (SBIR/STTR)
- Small business innovation research program phase i actionSR1
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 13
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2019/2019-0885-000
- 075-2020/2020-0885-000
- 075-2023/2023-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression